[C15H 6 Cl 6 O4], monoclinic, Cc (no. 9), a = 12.0980(11) Å,
Experimental details
All H atoms were included in calculated positions and refined as riding atoms, with C-H = 0.90−0.97 Å with U iso (H) = 1.5
Ueq(C) for methyl H atoms and 1.2 Ueq(C) for all other H atoms. The Flack-Parsons parameter is 0.039(18) based on 1283 quotients [2] . performed by using 2-aminopyridine and bis(2,4,6-trichlorophenyl)malonate [4, 5] . Nowadays, many pyrimidine and pyrimidopyrimidine derivatives are of interest in the search for new pharmaceutical candidates because they may show distinguished pharmaceutical properties, such as: antiviral, antibacterial, anti-HIV, antiallergic, and antitumoral activities [6] . Pyrimidines have a prominent pharmacophore prevailing in many heterocyclic natural products. During the past two decades, several pyrimidine derivatives were found to have widespread clinical applications including chemotherapy of AIDS.
Herein we report the synthesis and crystal structure of the intermediate of the pyrimidone synthesis [7] : bis(2,4,6-trichlorophenyl) malonate. In the molecule of the title compound (Fig.) , bond lengths and angles are in the expected ranges for malonates [8, 9] . Two aryl rings were bound to the both sides of malonic acid group. The dihedral angle between the benzene rings is 67.8°. Further, the dihedral angle between the central CH 2 -C(O)-O segment and the phenyl ring is 83.8°.
